Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Cancer. 2019 Oct 29;126(3):593–601. doi: 10.1002/cncr.32552

Figure 3: Association of MPAL phenotype and survival.

Figure 3:

(A) Five-year EFS rates for B/Myeloid compared to T/Myeloid MPAL were 73±10% versus 68±15% (p=0.860); five-year OS rates were 75±9% versus 80±12% (p=0.922).